Company Filing History:
Years Active: 2020
Title: Ichiro Takemasa: Innovator in Colon Cancer Detection
Introduction
Ichiro Takemasa is a notable inventor based in Suita, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of colon cancer. His innovative work has the potential to improve early detection rates and patient outcomes.
Latest Patents
Takemasa holds a patent for a multiplex colon cancer marker panel. This invention provides a specific combination of colon cancer markers based on statistical knowledge. It is capable of detecting a larger number of colon cancer patients in earlier stages while maintaining high specificity. The multiplex colon cancer marker panel comprises a combination of five colon cancer markers: Carcinoembryonic antigen-related cell adhesion molecule 5, Carbohydrate antigen 19-9, Galectin-4, APEX nuclease, and Actin-related protein 2. Additionally, he has developed a method for analyzing colon cancer markers using this panel.
Career Highlights
Throughout his career, Takemasa has worked with prominent organizations such as Shimadzu Corporation and Osaka University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Makoto Watanabe and Eiichi Matsuo. Their collaborative efforts have further advanced the research and development of cancer detection technologies.
Conclusion
Ichiro Takemasa's contributions to colon cancer detection through his innovative patent demonstrate his commitment to improving medical diagnostics. His work has the potential to significantly impact patient care and early detection strategies.